SQUID Embolization for Subdural Hematoma
(STEM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is testing a procedure that blocks a brain artery using SQUID to help patients with long-term brain bleeding. The goal is to see if this method is safe and effective.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. Please consult with the study team for guidance.
Is SQUID embolization safe for treating subdural hematomas?
Research shows that SQUID embolization is generally safe for treating chronic subdural hematomas, with studies reporting no complications during or after the procedure and significant reduction in hematoma size. In one study, patients over 80 experienced no complications, and another study found it to be a safe alternative treatment option.12345
How is the SQUID treatment different from other treatments for subdural hematoma?
SQUID treatment for subdural hematoma is unique because it involves a minimally invasive procedure called embolization, where a liquid agent is used to block blood flow in the middle meningeal artery, helping to reduce the hematoma without the need for direct surgical removal. This approach is particularly beneficial for elderly patients, as it offers a safer alternative with fewer complications compared to traditional surgical methods.23678
What data supports the effectiveness of the treatment SQUID for subdural hematoma?
Who Is on the Research Team?
David Fiorella, MD, PhD
Principal Investigator
Stony Brook University Medical Center
Adam Arthur, MD, MPH
Principal Investigator
Semmes-Murphy Neurologic and Spine Institute
Are You a Good Fit for This Trial?
The STEM trial is for adults aged 30 or older with chronic subdural hematoma (cSDH) that's at least 10 mm thick and causing brain pressure. Participants must have had a stable condition before the cSDH, be experiencing symptoms like headaches or weakness, and commit to follow-up visits. Pregnant women can't join, nor can those who've had certain prior head surgeries or conditions affecting the brain.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Middle Meningeal Artery (MMA) embolization with SQUID or receive standard management
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SQUID
Find a Clinic Near You
Who Is Running the Clinical Trial?
Balt USA
Lead Sponsor
Balt Extrusion
Industry Sponsor
Embo-Flüssigkeiten A.G.
Industry Sponsor
AXIOM Real Time Metrics
Collaborator